rethinkPeptides Search
Menu
Study breakdown

Bee venom peptide melittin prevents cardiac hypertrophy by targeting ACE and NF-κB pathways

evidence
The takeaway

Bee venom, with melittin as its dominant active peptide, prevented cardiac hypertrophy in mice by downregulating ACE, renin, and the JAK2/NF-κB inflammatory signaling cascade.

Dual ACE + NF-κB inhibition

Bee venom peptide melittin targets both the renin-angiotensin system and inflammatory pathways to prevent cardiac hypertrophy

What the researchers found

Melittin identified as dominant BV component. BV prevented ECG and echo abnormalities, reversed morphological and histological heart changes, downregulated hypertrophy markers (β-MHC, ANP, BNP), ACE, and IL-1β, and inhibited JAK2/NF-κB signaling in ISO-induced cardiac hypertrophy.

Why it matters

Cardiac hypertrophy progresses to heart failure, a leading cause of death. Bee venom peptides, particularly melittin, offer a natural peptide-based therapeutic approach targeting both the renin-angiotensin system and inflammatory pathways simultaneously.

How the study worked

UPLC-Q/TOF-MS for BV characterization, isoproterenol-induced cardiac hypertrophy in mice (in vivo) and cardiomyocytes (in vitro), ECG, echocardiography, histopathology, network pharmacology, Western blot, and RT-qPCR.

What this study cannot tell us

Preclinical study in mice. Bee venom is a complex mixture—clinical translation requires purified melittin. Safety profile of repeated melittin administration needs evaluation. ISO-induced hypertrophy is a simplified model.

How to read the evidence

Preclinical in vivo and in vitro study with network pharmacology validation. Good mechanistic evidence but limited to animal models.

When this study was published

Published in 2025.

The bigger picture

Venom-derived peptides continue to yield therapeutic candidates. Melittin's dual action on ACE/renin (blood pressure) and NF-κB (inflammation) pathways mirrors the multi-target approach increasingly valued in cardiovascular medicine.

Questions still open

  • Can purified melittin reproduce all of bee venom's cardioprotective effects?
  • How does melittin compare to ACE inhibitors for cardiac hypertrophy?
  • What is the therapeutic window for melittin given its known cytotoxicity?

Common questions

Can bee venom treat heart problems?
This preclinical study shows bee venom, primarily through its main peptide melittin, prevented abnormal heart muscle thickening in mice by reducing inflammation and blocking angiotensin-converting enzyme (ACE). However, this is early research and bee venom has known toxicity concerns that need to be addressed.
What is melittin?
Melittin is the main bioactive peptide in bee venom, making up about 50% of its dry weight. It is a 26-amino acid peptide known for membrane-disrupting activity. This study reveals it also has cardiovascular protective properties through ACE and NF-κB pathway modulation.

Read the original research

Bee venom alleviates isoproterenol-induced cardiac hypertrophy via JAK2/NF-κB signaling cascade.

Tissue & cell, 97, 103077

Citation

Shi, Peiying; Han, Shuo; Sun, Yang; Li, Mengmeng; Xu, Xueling. (2025). Bee venom alleviates isoproterenol-induced cardiac hypertrophy via JAK2/NF-κB signaling cascade.. Tissue & cell, 97, 103077. https://doi.org/10.1016/j.tice.2025.103077